trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-831,G002,4,2,320072.0
G002,G002-341,G002,4,2,216593.0
G002,G002-852,G002,4,1,407195.0
G002,G002-136,G002,4,2,576362.0
G002,G002-616,G002,4,1,280312.0
G002,G002-502,G002,4,1,353340.0
G002,G002-293,G002,4,2,181247.0
G002,G002-371,G002,4,3,544702.0
G002,G002-630,G002,4,2,741491.0
G002,G002-997,G002,4,3,119418.0
G002,G002-119,G002,4,2,229487.0
G002,G002-477,G002,4,3,545659.0
G002,G002-145,G002,4,2,193128.0
G002,G002-619,G002,4,1,125039.0
G002,G002-758,G002,4,1,181493.0
G002,G002-931,G002,4,3,186392.0
G002,G002-820,G002,4,2,551687.0
G002,G002-516,G002,4,1,397058.0
G002,G002-855,G002,4,2,278095.0
G002,G002-689,G002,4,3,62241.0
G002,G002-493,G002,4,2,29352.0
G002,G002-577,G002,4,2,186061.0
G002,G002-546,G002,4,1,420956.0
G002,G002-796,G002,4,3,148454.0
G002,G002-230,G002,4,2,620589.0
G002,G002-595,G002,4,3,301942.0
G002,G002-813,G002,4,1,107216.0
G002,G002-678,G002,4,1,126877.0
G002,G002-884,G002,4,3,371596.0
G002,G002-254,G002,4,1,237823.0
G002,G002-943,G002,4,2,280570.0
G002,G002-825,G002,4,3,77027.0
G002,G002-957,G002,4,2,227251.0
G002,G002-866,G002,4,3,349562.0
G002,G002-479,G002,4,1,427365.0
G002,G002-278,G002,4,3,155728.0
G002,G002-834,G002,4,1,120670.0
G002,G002-302,G002,4,1,113690.0
G002,G002-733,G002,4,1,332511.0
G002,G002-969,G002,4,1,355173.0
G002,G002-632,G002,4,3,294466.0
G002,G002-304,G002,4,3,35104.0
G002,G002-810,G002,4,3,283813.0
G002,G002-905,G002,4,1,49095.0
G002,G002-871,G002,4,3,284489.0
G002,G002-988,G002,4,3,298663.0
G002,G002-427,G002,4,3,65857.0
G002,G002-947,G002,4,2,188333.0
G002,G002-620,G002,4,2,69401.0
G002,G002-480,G002,4,2,114145.0
G002,G002-462,G002,4,3,99537.0
